This observation was corroborated by immunoblotting, which showed decreased levels of p-S6K and p-RPS6 upon alpelisib treatment in LIN28Bhi CRC cells (Figure 6D). This evidence concerns the gene RPS6KB1 and colorectal carcinoma.